CL2012000885A1 - Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico. - Google Patents

Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico.

Info

Publication number
CL2012000885A1
CL2012000885A1 CL2012000885A CL2012000885A CL2012000885A1 CL 2012000885 A1 CL2012000885 A1 CL 2012000885A1 CL 2012000885 A CL2012000885 A CL 2012000885A CL 2012000885 A CL2012000885 A CL 2012000885A CL 2012000885 A1 CL2012000885 A1 CL 2012000885A1
Authority
CL
Chile
Prior art keywords
compounds
pharmaceutical composition
inflammatory
phenyloxadiazole
pgds
Prior art date
Application number
CL2012000885A
Other languages
English (en)
Inventor
George Lee
Harpal S Gill
Andre Hillegass
Franz J Weiberth
Christopher L Vandeusen
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CL2012000885A1 publication Critical patent/CL2012000885A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCIÓN SE REFIERE A UN COMPUESTO DE FÓRMULA (1): EN LA QUE RL, R2 Y R3 SON COMO SE DEFINEN EN LA PRESENTE MEMORIA, A UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE EL COMPUESTO, COMPUESTOS INTERMEDIARIOS Y A UN PROCEDIMIENTO PARA FABRICAR DICHOS COMPUESTOS, Y AL USO DEL COMPUESTO PARA TRATAR TRASTORNOS INFLAMATORIOS Y/O ALÉRGICOS, PARTICULARMENTE TRASTORNOS TALES COMO RINITIS ALÉRGICA, ASMA, ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (COPD) Y DEGENERACIÓN MACULAR RELACIONADA CON LA EDAD (AMD).
CL2012000885A 2009-10-08 2012-04-05 Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico. CL2012000885A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24969309P 2009-10-08 2009-10-08
FR1056094 2010-07-26

Publications (1)

Publication Number Publication Date
CL2012000885A1 true CL2012000885A1 (es) 2012-08-31

Family

ID=69650455

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000885A CL2012000885A1 (es) 2009-10-08 2012-04-05 Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico.

Country Status (2)

Country Link
US (2) US20200383982A1 (es)
CL (1) CL2012000885A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12617797B2 (en) 2020-05-27 2026-05-05 Esteve Pharmaceuticals, S.A. Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12617797B2 (en) 2020-05-27 2026-05-05 Esteve Pharmaceuticals, S.A. Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain

Also Published As

Publication number Publication date
US20200383982A1 (en) 2020-12-10
US20210330671A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
UY29840A1 (es) Compuestos de pirimidina amida como inhibidores de pgds
UY32938A (es) Derivados de feniloxadiazol como agentes inhibidores de las pgds
ECSP088741A (es) Derivados de benzotriazol como agonistas del adrenoreceptor beta2
MX353461B (es) PROCESOS PARA PREPARAR COMPUESTOS ÚTILES COMO INHIBIDORES DE CINASA ATAXIA TELANGIECTASIA MUTADA Y Rad3 RELACIONADOS (ATR).
ECSP14013173A (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida
CO2019008986A2 (es) Derivados de tirosinamida como inhibidores de rho-quinasa
SV2009002861A (es) Compuestos de pirimidina amida como inhibidores de pgds
BR112013023517A2 (pt) "inibidores de produção de leucotrieno, seus usos, e composição farmacêutica"
BR112013025387A2 (pt) análogos substituídos da n-fenilpirimidin-2-amina como inibidores da quinase axl
GT200900289A (es) Compuestos organicos.-
MX345763B (es) Nuevos macrociclos como inhibidores del factor xia.
CU20160167A7 (es) Compuestos de pirazolopiridinas y pirazolopirimidinas útiles en el tratamiento de condiciones alérgicas y respiratorias
BR112015020350A2 (pt) derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida e seu uso como inibidores de phd
CY1122500T1 (el) Φαρμακευτικη συνθεση που περιεχει παραγωγα γλουταριμιδιου, και εφαρμογη αυτης για την αγωγη ηωσινοφιλικων νοσων
ECSP13012494A (es) Inhibidores de oxadiazol de la producción de leucotrieno.
CU24187B1 (es) Derivados sustituidos de imidazopiridazinas útiles para el tratamiento o profilaxis de trastornos hiperproliferativos y la angiogénesis
PH12014501319A1 (en) Substituted triazolopyridines and their use as ttk inhibitors
UY34959A (es) Dihidropiridona p1 como inhibidores del factor xia
CR20130693A (es) Composición farmacéutica ortalmológica tópica que contiene regorafenib
AR080527A1 (es) Una pirimidina sustituida como un antagonista del receptor de la postaglandina d2
MX2010008685A (es) Farmacoforos duales-antagonistas muscarinicos de pde4.
WO2013040412A3 (en) Methods for inhibiting bacteria growth
AU2012312301A8 (en) Compounds useful as inhibitors of choline kinase
UY30988A1 (es) Compuestos de pirimidina hidrazida como inhibidores de pgds
CU20100214A7 (es) Imidazoquinolinas como inhibidores de cinasa de lípido